GLOBAL AND JAPAN ANTI-OBESITY PRESCRIPTION DRUGS MARKET 2020 BY MANUFACTURERS, TYPE AND APPLICATION, FORECAST TO 2025

Mar 2020 93
Table of Contents

1 Market Overview
1.1 Anti-Obesity Prescription Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti-Obesity Prescription Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Orlistat
1.2.3 Phentermine and Topiramate
1.2.4 Bupropion and Naltrexone
1.2.5 Lorcaserin
1.2.6 Liraglutide
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti-Obesity Prescription Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pediatric
1.3.3 Adult
1.4 Global Anti-Obesity Prescription Drugs Market Size and Forecast (2015-2025)
1.4.1 Global Anti-Obesity Prescription Drugs Revenue and Forecast (2015-2025)
1.4.2 Global Anti-Obesity Prescription Drugs Sales and Forecast (2015-2025)
1.5 Global Anti-Obesity Prescription Drugs Market Size Overview by Geography (2015-2020)
2 Manufacturers Profiles
2.1 F Hoffmann La Roche Ltd
2.1.1 F Hoffmann La Roche Ltd Details
2.1.2 F Hoffmann La Roche Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 F Hoffmann La Roche Ltd SWOT Analysis
2.1.4 F Hoffmann La Roche Ltd Product and Services
2.1.5 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Alizyme
2.2.1 Alizyme Details
2.2.2 Alizyme Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Alizyme SWOT Analysis
2.2.4 Alizyme Product and Services
2.2.5 Alizyme Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Arena Pharmaceuticals
2.3.1 Arena Pharmaceuticals Details
2.3.2 Arena Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Arena Pharmaceuticals SWOT Analysis
2.3.4 Arena Pharmaceuticals Product and Services
2.3.5 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Orexigen Therapeutics
2.4.1 Orexigen Therapeutics Details
2.4.2 Orexigen Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Orexigen Therapeutics SWOT Analysis
2.4.4 Orexigen Therapeutics Product and Services
2.4.5 Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Boehringer Ingelheim
2.5.1 Boehringer Ingelheim Details
2.5.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Boehringer Ingelheim SWOT Analysis
2.5.4 Boehringer Ingelheim Product and Services
2.5.5 Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novo Nordisk A/s
2.6.1 Novo Nordisk A/s Details
2.6.2 Novo Nordisk A/s Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novo Nordisk A/s SWOT Analysis
2.6.4 Novo Nordisk A/s Product and Services
2.6.5 Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Vivus
2.7.1 Vivus Details
2.7.2 Vivus Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Vivus SWOT Analysis
2.7.4 Vivus Product and Services
2.7.5 Vivus Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Glaxosmithkline
2.8.1 Glaxosmithkline Details
2.8.2 Glaxosmithkline Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Glaxosmithkline SWOT Analysis
2.8.4 Glaxosmithkline Product and Services
2.8.5 Glaxosmithkline Anti-Obesity Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Global Anti-Obesity Prescription Drugs Market, Company Landscape
3.1 Company Market Share Analysis: Global
3.1.1 Global Anti-Obesity Prescription Drugs Sales and Market Share by Manufacturer (2018-2019)
3.1.2 Global Anti-Obesity Prescription Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.2 Company Market Share Analysis: Japan
3.2.1 Key Players Anti-Obesity Prescription Drugs Sales in Japan (2018-2019)
3.2.2 Japan Anti-Obesity Prescription Drugs Revenue Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Anti-Obesity Prescription Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Anti-Obesity Prescription Drugs Manufacturer Market Share in 2019
4 Market Size by Geography
4.1 Global Anti-Obesity Prescription Drugs Market Size by Geography (2015-2020)
4.1.1 Global Anti-Obesity Prescription Drugs Sales by Geography (2015-2020)
4.1.2 Global Anti-Obesity Prescription Drugs Revenue by Regions (2015-2020)
4.2 Global Anti-Obesity Prescription Drugs Market Size and Forecast by Regions (2020-2025)
4.2.1 Global Anti-Obesity Prescription Drugs Sales and Forecast by Regions (2020-2025)
4.2.2 Global Anti-Obesity Prescription Drugs Revenue and Forecast by Regions (2020-2025)
4.3 North America Anti-Obesity Prescription Drugs Market Size and Forecast (2015-2025)
4.4 Europe Anti-Obesity Prescription Drugs Market Size and Forecast (2015-2025)
4.5 Asia-Pacific Anti-Obesity Prescription Drugs Market Size and Forecast (2015-2025)
4.6 South America Anti-Obesity Prescription Drugs Market Size and Forecast (2015-2025)
4.7 Middle East and Africa Anti-Obesity Prescription Drugs Market Size and Forecast (2015-2025)
5 North America by Country
5.1 North America Anti-Obesity Prescription Drugs Market Size by Country (2015-2020)
5.1.1 North America Anti-Obesity Prescription Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Anti-Obesity Prescription Drugs Revenue and Market Share by Country (2015-2020)
5.2 North America Anti-Obesity Prescription Drugs Market Size and Forecast by Country (2020-2025)
5.2.1 North America Anti-Obesity Prescription Drugs Sales and Forecast by Country (2020-2025)
5.2.2 North America Anti-Obesity Prescription Drugs Revenue and Forecast by Country (2020-2025)
5.3 United States Anti-Obesity Prescription Drugs Market Size and Forecast (2015-2025)
5.4 Canada Anti-Obesity Prescription Drugs Market Size and Forecast (2015-2025)
5.5 Mexico Anti-Obesity Prescription Drugs Market Size and Forecast (2015-2025)
6 Europe by Country
6.1 Europe Anti-Obesity Prescription Drugs Market Size by Country (2015-2020)
6.1.1 Europe Anti-Obesity Prescription Drugs Sales by Country (2015-2020)
6.1.2 Europe Anti-Obesity Prescription Drugs Revenue by Country (2015-2020)
6.2 Europe Anti-Obesity Prescription Drugs Market Size and Forecast by Country (2020-2025)
6.2.1 Europe Anti-Obesity Prescription Drugs Sales and Forecast by Country (2020-2025)
6.2.2 Europe Anti-Obesity Prescription Drugs Revenue and Forecast by Country (2020-2025)
6.3 Germany Anti-Obesity Prescription Drugs Market Size and Forecast (2015-2025)
6.4 United Kingdom Anti-Obesity Prescription Drugs Market Size and Forecast (2015-2025)
6.5 France Anti-Obesity Prescription Drugs Market Size and Forecast (2015-2025)
6.6 Russia Anti-Obesity Prescription Drugs Market Size and Forecast (2015-2025)
6.7 Italy Anti-Obesity Prescription Drugs Market Size and Forecast (2015-2025)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Anti-Obesity Prescription Drugs Market Size by Region (2015-2020)
7.1.1 Asia-Pacific Anti-Obesity Prescription Drugs Sales by Region (2015-2020)
7.1.2 Asia-Pacific Anti-Obesity Prescription Drugs Revenue by Region (2015-2020)
7.2 Asia-Pacific Anti-Obesity Prescription Drugs Market Size and Forecast by Region (2020-2025)
7.2.1 Asia-Pacific Anti-Obesity Prescription Drugs Sales and Forecast by Region (2020-2025)
7.2.2 Asia-Pacific Anti-Obesity Prescription Drugs Revenue and Forecast by Region (2020-2025)
7.3 China Anti-Obesity Prescription Drugs Market Size and Forecast (2015-2025)
7.4 Japan Anti-Obesity Prescription Drugs Market Size and Forecast (2015-2025)
7.5 Korea Anti-Obesity Prescription Drugs Market Size and Forecast (2015-2025)
7.6 India Anti-Obesity Prescription Drugs Market Size and Forecast (2015-2025)
7.7 Southeast Asia Anti-Obesity Prescription Drugs Market Size and Forecast (2015-2025)
7.8 Australia Anti-Obesity Prescription Drugs Market Size and Forecast (2015-2025)
8 South America by Country
8.1 South America Anti-Obesity Prescription Drugs Market Size by Country (2015-2020)
8.1.1 South America Anti-Obesity Prescription Drugs Sales by Country (2015-2020)
8.1.2 South America Anti-Obesity Prescription Drugs Revenue by Country (2015-2020)
8.2 South America Anti-Obesity Prescription Drugs Market Size and Forecast by Country (2020-2025)
8.2.1 South America Anti-Obesity Prescription Drugs Sales and Forecast by Country (2020-2025)
8.2.2 South America Anti-Obesity Prescription Drugs Revenue and Forecast by Country (2020-2025)
8.3 Brazil Anti-Obesity Prescription Drugs Market Size and Forecast (2015-2025)
8.4 Argentina Anti-Obesity Prescription Drugs Market Size and Forecast (2015-2025)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Anti-Obesity Prescription Drugs Market Size by Country (2015-2020)
9.1.1 Middle East & Africa Anti-Obesity Prescription Drugs Sales by Country (2015-2020)
9.1.2 Middle East & Africa Anti-Obesity Prescription Drugs Revenue by Country (2015-2020)
9.2 Middle East & Africa Anti-Obesity Prescription Drugs Market Size and Forecast by Country (2020-2025)
9.2.1 Middle East & Africa Anti-Obesity Prescription Drugs Sales and Forecast by Country (2020-2025)
9.2.2 Middle East & Africa Anti-Obesity Prescription Drugs Revenue and Forecast by Country (2020-2025)
9.3 Saudi Arabia Anti-Obesity Prescription Drugs Market Size and Forecast (2015-2025)
9.4 Turkey Anti-Obesity Prescription Drugs Market Size and Forecast (2015-2025)
9.5 Egypt Anti-Obesity Prescription Drugs Market Size and Forecast (2015-2025)
9.6 South Africa Anti-Obesity Prescription Drugs Market Size and Forecast (2015-2025)
10 Market Segment by Type
10.1 Global Anti-Obesity Prescription Drugs Market Size by Type (2015-2020)
10.1.1 Global Anti-Obesity Prescription Drugs Sales by Type (2015-2020)
10.1.2 Global Anti-Obesity Prescription Drugs Revenue by Type (2015-2020)
10.1.3 Global Anti-Obesity Prescription Drugs Price by Type (2015-2020)
10.2 Global Anti-Obesity Prescription Drugs Market Size and Forecast by Type (2020-2025)
10.2.1 Global Anti-Obesity Prescription Drugs Sales and Forecast by Type (2020-2025)
10.2.2 Global Anti-Obesity Prescription Drugs Revenue and Forecast by Type (2020-2025)
10.2.3 Global Anti-Obesity Prescription Drugs Price and Forecast by Type (2020-2025)
10.3 Japan Anti-Obesity Prescription Drugs Market Size and Forecast by Type (2015-2025)
10.3.1 Japan Anti-Obesity Prescription Drugs Market Size by Type (2015-2020)
10.3.2 Japan Anti-Obesity Prescription Drugs Market Size and Forecast by Type (2020-2025)
11 Market Segment by Application
11.1 Global Anti-Obesity Prescription Drugs Market Size by Application (2015-2020)
11.1.1 Global Anti-Obesity Prescription Drugs Sales by Application (2015-2020)
11.1.2 Global Anti-Obesity Prescription Drugs Revenue by Application (2015-2020)
11.1.3 Global Anti-Obesity Prescription Drugs Price by Application (2015-2020)
11.2 Global Anti-Obesity Prescription Drugs Market Size and Forecast by Application (2020-2025)
11.2.1 Global Anti-Obesity Prescription Drugs Sales and Forecast by Application (2020-2025)
11.2.2 Global Anti-Obesity Prescription Drugs Revenue and Forecast by Application (2020-2025)
11.2.3 Global Anti-Obesity Prescription Drugs Price and Forecast by Application (2020-2025)
11.3 Japan Anti-Obesity Prescription Drugs Market Size and Forecast by Application (2015-2025)
11.3.1 Japan Anti-Obesity Prescription Drugs Market Size by Application (2015-2020)
11.3.2 Japan Anti-Obesity Prescription Drugs Market Size and Forecast by Application (2020-2025)
12 Sales Channel, Distributors, Costumers, and Market Dynamics
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Distributors, Traders and Dealers
12.4.1 Market Opportunities
12.4.2 Market Risk
12.4.3 Market Driving Force
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Anti-Obesity Prescription Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Anti-Obesity Prescription Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Anti-Obesity Prescription Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Anti-Obesity Prescription Drugs Market Size Overview by Geography (2015-2020) (USD Million)
Table 5. F Hoffmann La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 6. F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Major Business
Table 7. F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Total Revenue (USD Million) (2018-2019)
Table 8. F Hoffmann La Roche Ltd SWOT Analysis
Table 9. F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Product and Services
Table 10. F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales (K g), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 11. Alizyme Basic Information, Manufacturing Base and Competitors
Table 12. Alizyme Anti-Obesity Prescription Drugs Major Business
Table 13. Alizyme Anti-Obesity Prescription Drugs Total Revenue (USD Million) (2018-2019)
Table 14. Alizyme SWOT Analysis
Table 15. Alizyme Anti-Obesity Prescription Drugs Product and Services
Table 16. Alizyme Anti-Obesity Prescription Drugs Sales (K g), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 17. Arena Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 18. Arena Pharmaceuticals Anti-Obesity Prescription Drugs Major Business
Table 19. Arena Pharmaceuticals Anti-Obesity Prescription Drugs Total Revenue (USD Million) (2018-2019)
Table 20. Arena Pharmaceuticals SWOT Analysis
Table 21. Arena Pharmaceuticals Anti-Obesity Prescription Drugs Product and Services
Table 22. Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales (K g), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 23. Orexigen Therapeutics Basic Information, Manufacturing Base and Competitors
Table 24. Orexigen Therapeutics Anti-Obesity Prescription Drugs Major Business
Table 25. Orexigen Therapeutics Anti-Obesity Prescription Drugs Total Revenue (USD Million) (2018-2019)
Table 26. Orexigen Therapeutics SWOT Analysis
Table 27. Orexigen Therapeutics Anti-Obesity Prescription Drugs Product and Services
Table 28. Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales (K g), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 29. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 30. Boehringer Ingelheim Anti-Obesity Prescription Drugs Major Business
Table 31. Boehringer Ingelheim Anti-Obesity Prescription Drugs Total Revenue (USD Million) (2018-2019)
Table 32. Boehringer Ingelheim SWOT Analysis
Table 33. Boehringer Ingelheim Anti-Obesity Prescription Drugs Product and Services
Table 34. Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales (K g), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 35. Novo Nordisk A/s Basic Information, Manufacturing Base and Competitors
Table 36. Novo Nordisk A/s Anti-Obesity Prescription Drugs Major Business
Table 37. Novo Nordisk A/s Anti-Obesity Prescription Drugs Total Revenue (USD Million) (2018-2019)
Table 38. Novo Nordisk A/s SWOT Analysis
Table 39. Novo Nordisk A/s Anti-Obesity Prescription Drugs Product and Services
Table 40. Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales (K g), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 41. Vivus Basic Information, Manufacturing Base and Competitors
Table 42. Vivus Anti-Obesity Prescription Drugs Major Business
Table 43. Vivus Anti-Obesity Prescription Drugs Total Revenue (USD Million) (2018-2019)
Table 44. Vivus SWOT Analysis
Table 45. Vivus Anti-Obesity Prescription Drugs Product and Services
Table 46. Vivus Anti-Obesity Prescription Drugs Sales (K g), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 47. Glaxosmithkline Basic Information, Manufacturing Base and Competitors
Table 48. Glaxosmithkline Anti-Obesity Prescription Drugs Major Business
Table 49. Glaxosmithkline Anti-Obesity Prescription Drugs Total Revenue (USD Million) (2018-2019)
Table 50. Glaxosmithkline SWOT Analysis
Table 51. Glaxosmithkline Anti-Obesity Prescription Drugs Product and Services
Table 52. Glaxosmithkline Anti-Obesity Prescription Drugs Sales (K g), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 53. Global Anti-Obesity Prescription Drugs Sales by Manufacturer (2018-2019) (K g)
Table 54. Global Anti-Obesity Prescription Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 55. Key Players Anti-Obesity Prescription Drugs Sales in Japan (2018-2019) (K g)
Table 56. Key Players Anti-Obesity Prescription Drugs Sales Market Share in Japan (2018-2019)
Table 57. Key Players Revenue of Anti-Obesity Prescription Drugs in Japan (2018-2019) (USD Million)
Table 58. Global Anti-Obesity Prescription Drugs Sales by Regions (2015-2020) (K g)
Table 59. Global Anti-Obesity Prescription Drugs Sales Market Share by Regions (2015-2020)
Table 60. Global Anti-Obesity Prescription Drugs Revenue by Regions (2015-2020) (USD Million)
Table 61. Global Anti-Obesity Prescription Drugs Sales and Forecast by Regions (2020-2025) (K g)
Table 62. Global Anti-Obesity Prescription Drugs Sales Market Share by Regions (2020-2025)
Table 63. Global Anti-Obesity Prescription Drugs Revenue and Forecast by Regions (2020-2025) (USD Million)
Table 64. Global Anti-Obesity Prescription Drugs Revenue Market Share by Regions (2020-2025) (USD Million)
Table 65. North America Anti-Obesity Prescription Drugs Sales by Countries (2015-2020) (K g)
Table 66. North America Anti-Obesity Prescription Drugs Sales Market Share by Countries (2015-2020)
Table 67. North America Anti-Obesity Prescription Drugs Revenue by Countries (2015-2020) (USD Million)
Table 68. North America Anti-Obesity Prescription Drugs Revenue Market Share by Countries (2015-2020)
Table 69. North America Anti-Obesity Prescription Drugs Sales by Country (2020-2025) (K g)
Table 70. North America Anti-Obesity Prescription Drugs Sales Market Share by Country (2020-2025)
Table 71. North America Anti-Obesity Prescription Drugs Revenue by Country (2020-2025) (USD Million)
Table 72. North America Anti-Obesity Prescription Drugs Revenue Market Share by Country (2020-2025)
Table 73. Europe Anti-Obesity Prescription Drugs Sales by Countries (2015-2020) (K g)
Table 74. Europe Anti-Obesity Prescription Drugs Sales Market Share by Countries (2015-2020)
Table 75. Europe Anti-Obesity Prescription Drugs Revenue by Countries (2015-2020) (USD Million)
Table 76. Europe Anti-Obesity Prescription Drugs Revenue Market Share by Countries (2015-2020)
Table 77. Europe Anti-Obesity Prescription Drugs Sales by Country (2020-2025) (K g)
Table 78. Europe Anti-Obesity Prescription Drugs Sales Market Share by Country (2020-2025)
Table 79. Europe Anti-Obesity Prescription Drugs Revenue by Country (2020-2025) (USD Million)
Table 80. Europe Anti-Obesity Prescription Drugs Revenue Market Share by Country (2020-2025)
Table 81. Asia-Pacific Anti-Obesity Prescription Drugs Sales by Countries (2015-2020) (K g)
Table 82. Asia-Pacific Anti-Obesity Prescription Drugs Sales Market Share by Countries (2015-2020)
Table 83. Asia-Pacific Anti-Obesity Prescription Drugs Revenue by Countries (2015-2020) (USD Million)
Table 84. Asia-Pacific Anti-Obesity Prescription Drugs Revenue Market Share by Countries (2015-2020)
Table 85. Asia-Pacific Anti-Obesity Prescription Drugs Sales by Country (2020-2025) (K g)
Table 86. Asia-Pacific Anti-Obesity Prescription Drugs Sales Market Share by Country (2020-2025)
Table 87. Asia-Pacific Anti-Obesity Prescription Drugs Revenue by Country (2020-2025) (USD Million)
Table 88. Asia-Pacific Anti-Obesity Prescription Drugs Revenue Market Share by Country (2020-2025)
Table 89. South America Anti-Obesity Prescription Drugs Sales by Countries (2015-2020) (K g)
Table 90. South America Anti-Obesity Prescription Drugs Sales Market Share by Countries (2015-2020)
Table 91. South America Anti-Obesity Prescription Drugs Revenue by Countries (2015-2020) (USD Million)
Table 92. South America Anti-Obesity Prescription Drugs Revenue Market Share by Countries (2015-2020)
Table 93. South America Anti-Obesity Prescription Drugs Sales by Country (2020-2025) (K g)
Table 94. South America Anti-Obesity Prescription Drugs Sales Market Share by Country (2020-2025)
Table 95. South America Anti-Obesity Prescription Drugs Revenue by Country (2020-2025) (USD Million)
Table 96. South America Anti-Obesity Prescription Drugs Revenue Market Share by Country (2020-2025)
Table 97. Middle East & Africa Anti-Obesity Prescription Drugs Sales by Countries (2015-2020) (K g)
Table 98. Middle East & Africa Anti-Obesity Prescription Drugs Sales Market Share by Countries (2015-2020)
Table 99. Middle East & Africa Anti-Obesity Prescription Drugs Revenue by Countries (2015-2020) (USD Million)
Table 100. Middle East & Africa Anti-Obesity Prescription Drugs Revenue Market Share by Countries (2015-2020)
Table 101. Middle East & Africa Anti-Obesity Prescription Drugs Sales by Country (2020-2025) (K g)
Table 102. Middle East & Africa Anti-Obesity Prescription Drugs Sales Market Share by Country (2020-2025)
Table 103. Middle East & Africa Anti-Obesity Prescription Drugs Revenue by Country (2020-2025) (USD Million)
Table 104. Middle East & Africa Anti-Obesity Prescription Drugs Revenue Market Share by Country (2020-2025)
Table 105. Japan Anti-Obesity Prescription Drugs Sales by Type (2015-2020) (K g)
Table 106. Japan Anti-Obesity Prescription Drugs Sales Market Share by Type (2015-2020)
Table 107. Japan Anti-Obesity Prescription Drugs Revenue by Type (2015-2020) (USD Million)
Table 108. Japan Anti-Obesity Prescription Drugs Revenue Market Share by Type (2015-2020)
Table 109. Japan Anti-Obesity Prescription Drugs Sales by Type (2020-2025) (K g)
Table 110. Japan Anti-Obesity Prescription Drugs Sales Market Share by Type (2020-2025)
Table 111. Japan Anti-Obesity Prescription Drugs Revenue by Type (2020-2025) (USD Million)
Table 112. Japan Anti-Obesity Prescription Drugs Revenue Market Share by Type (2020-2025)
Table 113. Global Anti-Obesity Prescription Drugs Sales by Application (2015-2020) (K g)
Table 114. Global Anti-Obesity Prescription Drugs Sales Market Share by Application (2015-2020)
Table 115. Global Anti-Obesity Prescription Drugs Revenue by Application (2015-2020) (USD Million)
Table 116. Global Anti-Obesity Prescription Drugs Revenue Market Share by Application (2015-2020)
Table 117. Global Anti-Obesity Prescription Drugs Price by Application (2015-2020) (USD/MT)
Table 118. Global Anti-Obesity Prescription Drugs Sales by Application (2020-2025) (K g)
Table 119. Global Anti-Obesity Prescription Drugs Sales Market Share by Application (2020-2025)
Table 120. Global Anti-Obesity Prescription Drugs Revenue by Application (2020-2025) (USD Million)
Table 121. Global Anti-Obesity Prescription Drugs Revenue Market Share by Application (2020-2025)
Table 122. Global Anti-Obesity Prescription Drugs Price by Application (2020-2025) (USD/MT)
Table 123. Japan Anti-Obesity Prescription Drugs Sales by Application (2015-2020) (K g)
Table 124. Japan Anti-Obesity Prescription Drugs Sales Market Share by Application (2015-2020)
Table 125. Japan Anti-Obesity Prescription Drugs Revenue by Application (2015-2020) (USD Million)
Table 126. Japan Anti-Obesity Prescription Drugs Revenue Market Share by Application (2015-2020)
Table 127. Japan Anti-Obesity Prescription Drugs Sales by Application (2020-2025) (K g)
Table 128. Japan Anti-Obesity Prescription Drugs Sales Market Share by Application (2020-2025)
Table 129. Japan Anti-Obesity Prescription Drugs Revenue by Application (2020-2025) (USD Million)
Table 130. Japan Anti-Obesity Prescription Drugs Revenue Market Share by Application (2020-2025)
Table 131. Direct Channel Pros & Cons
Table 132. Indirect Channel Pros & Cons
Table 133. Distributors/Traders/ Dealers List
Table 134. Customers of Anti-Obesity Prescription Drugs
Table 135. Market Opportunities in Next Few Years
Table 136. Market Risks Analysis
Table 137. Market Drivers

List of Figures

Figure 1. Anti-Obesity Prescription Drugs Picture
Figure 2. Global Anti-Obesity Prescription Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Orlistat Picture
Figure 4. Phentermine and Topiramate Picture
Figure 5. Bupropion and Naltrexone Picture
Figure 6. Lorcaserin Picture
Figure 7. Liraglutide Picture
Figure 8. Anti-Obesity Prescription Drugs Sales Market Share by Application in 2019
Figure 9. Pediatric Picture
Figure 10. Adult Picture
Figure 11. Global Anti-Obesity Prescription Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 12. Global Anti-Obesity Prescription Drugs Sales Growth Rate (2015-2025) (K g)
Figure 13. Global Anti-Obesity Prescription Drugs Sales Market Share by Manufacturer in 2019
Figure 14. Global Anti-Obesity Prescription Drugs Revenue Market Share by Manufacturer in 2019
Figure 15. Key Players Anti-Obesity Prescription Drugs Revenue Market Share in Japan in 2019
Figure 16. Global Top 5 Anti-Obesity Prescription Drugs Manufacturer Market Share in 2019
Figure 17. Top 3 Anti-Obesity Prescription Drugs Players Market Share in Japan in 2019
Figure 18. Global Anti-Obesity Prescription Drugs Revenue Market Share by Regions in 2019
Figure 19. North America Anti-Obesity Prescription Drugs Sales YoY Growth (2015-2025) (K g)
Figure 20. North America Anti-Obesity Prescription Drugs Revenue YoY Growth (2015-2025) (USD Million)
Figure 21. Europe Anti-Obesity Prescription Drugs Sales YoY Growth (2015-2020) (K g)
Figure 22. Europe Anti-Obesity Prescription Drugs Revenue YoY Growth (2015-2020) (USD Million)
Figure 23. Asia-Pacific Anti-Obesity Prescription Drugs Sales YoY Growth (2015-2020) (K g)
Figure 24. Asia-Pacific Anti-Obesity Prescription Drugs Revenue YoY Growth (2015-2020) (USD Million)
Figure 25. South America Anti-Obesity Prescription Drugs Sales YoY Growth (2015-2020) (K g)
Figure 26. South America Anti-Obesity Prescription Drugs Revenue YoY Growth (2015-2020) (USD Million)
Figure 27. Middle East & Africa Anti-Obesity Prescription Drugs Sales YoY Growth (2015-2020) (K g)
Figure 28. Middle East & Africa Anti-Obesity Prescription Drugs Revenue YoY Growth (2015-2020) (USD Million)
Figure 29. North America Anti-Obesity Prescription Drugs Sales Market Share by Country in 2019
Figure 30. North America Anti-Obesity Prescription Drugs Revenue Market Share by Country in 2019
Figure 31. United States Anti-Obesity Prescription Drugs Market Size and Growth Rate (2015-2025) (USD Million)
Figure 32. Canada Anti-Obesity Prescription Drugs Market Size and Growth Rate (2015-2025) (USD Million)
Figure 33. Mexico Anti-Obesity Prescription Drugs Market Size and Growth Rate (2015-2020) (USD Million)
Figure 34. Europe Anti-Obesity Prescription Drugs Revenue Market Share by Country in 2019
Figure 35. Germany Anti-Obesity Prescription Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 36. United Kingdom Anti-Obesity Prescription Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 37. France Anti-Obesity Prescription Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 38. Russia Anti-Obesity Prescription Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 39. Italy Anti-Obesity Prescription Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 40. Asia-Pacific Anti-Obesity Prescription Drugs Sales Market Share by Region 2018
Figure 41. Asia-Pacific Anti-Obesity Prescription Drugs Revenue Market Share by Region 2018
Figure 42. China Anti-Obesity Prescription Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 43. Japan Anti-Obesity Prescription Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 44. Korea Anti-Obesity Prescription Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 45. India Anti-Obesity Prescription Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 46. Southeast Asia Anti-Obesity Prescription Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 47. Australia Anti-Obesity Prescription Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 48. South America Anti-Obesity Prescription Drugs Sales Market Share by Country in 2019
Figure 49. South America Anti-Obesity Prescription Drugs Revenue Market Share by Country in 2019
Figure 50. Brazil Anti-Obesity Prescription Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 51. Argentina Anti-Obesity Prescription Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 52. Saudi Arabia Anti-Obesity Prescription Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 53. Turkey Anti-Obesity Prescription Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 54. Egypt Anti-Obesity Prescription Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 55. South Africa Anti-Obesity Prescription Drugs Market Size Growth Rate (2015-2025) (USD Million)
Figure 56. Global Revenue Market Share of Anti-Obesity Prescription Drugs by Type in 2019
Figure 57. Global Revenue Market Share of Anti-Obesity Prescription Drugs by Application in 2019
Figure 58. Sales Channel: Direct Channel vs Indirect Channel

Table of Contents

Related reports :

(Mar 20)

Market Overview The global Artesunate market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CA...

(Mar 20)

Market Overview The global Plant Sources Anti Cancer Agents market size is expected to gain market growth in the forecast period of 2...

(Mar 20)

Market Overview The global Hydroxycamptothecin market size is expected to gain market growth in the forecast period of 2020 to 2025, ...

(Mar 20)

Market Overview The global Irinotecan market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CA...

(Mar 20)

Market Overview The global Medical Protective Packaging market size is expected to gain market growth in the forecast period of 2020 ...

(Mar 20)

Market Overview The global Vinorelbine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a C...

Global Info Research

GLOBAL AND JAPAN ANTI-OBESITY PRESCRIPTION DRUGS MARKET 2020 BY MANUFACTURERS, TYPE AND APPLICATION, FORECAST TO 2025

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy